We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCRN
2526
DELISTED
Milacron Holdings Corp.
MCRN
| $286K | ﹤0.01% |
15,356
-386
| -2% | -$6.99K |
|
|
FPI
2527
Farmland Partners
FPI
$407M
| $285K | ﹤0.01% |
25,504
+13,292
| +109% | +$146K |
|
2528
Northern Oil and Gas
NOG
$2.3B
| $284K | ﹤0.01% |
10,926
+2,329
| +27% | +$71.4K |
|
2529
United States Lime & Minerals
USLM
$3.17B
| $284K | ﹤0.01% |
18,010
+65
| +0.4% | +$992 |
|
2530
Weyco Group
WEYS
$371M
| $284K | ﹤0.01% |
10,099
+197
| +2% | +$5.54K |
|
2531
QuinStreet
QNST
$890M
| $283K | ﹤0.01% |
72,613
+19,571
| +37% | +$68.8K |
|
2532
Digimarc Corp
DMRC
$147M
| $282K | ﹤0.01% |
10,445
+361
| +4% | +$9.45K |
|
2533
Village Super Market
VLGEA
$652M
| $282K | ﹤0.01% |
10,623
+183
| +2% | +$5.32K |
|
|
CUTR
2534
DELISTED
Cutera, Inc.
CUTR
| $282K | ﹤0.01% |
13,640
+549
| +4% | +$10.8K |
|
2535
Addus HomeCare
ADUS
$2.15B
| $281K | ﹤0.01% |
8,791
+283
| +3% | +$9.57K |
|
|
CIO
2536
DELISTED
City Office REIT
CIO
| $280K | ﹤0.01% |
23,024
+4,309
| +23% | +$54.3K |
|
|
STS
2537
DELISTED
Supreme Industries Inc Class A
STS
| $280K | ﹤0.01% |
13,817
+508
| +4% | +$9.5K |
|
2538
The Bancorp
TBBK
$2.79B
| $279K | ﹤0.01% |
54,715
+2,195
| +4% | +$12.6K |
|
|
MCBC
2539
DELISTED
Macatawa Bank Corp
MCBC
| $279K | ﹤0.01% |
28,217
+1,235
| +5% | +$12.4K |
|
|
CLD
2540
DELISTED
Cloud Peak Energy Inc
CLD
| $279K | ﹤0.01% |
60,809
+42,074
| +225% | +$212K |
|
2541
Limoneira
LMNR
$235M
| $278K | ﹤0.01% |
13,293
+549
| +4% | +$10.2K |
|
|
SRGA
2542
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $278K | ﹤0.01% |
2,321
+14
| +0.6% | +$1.46K |
|
|
RXDX
2543
DELISTED
Ignyta, Inc.
RXDX
| $277K | ﹤0.01% |
32,221
+3,347
| +12% | +$24.5K |
|
2544
Clean Energy Fuels
CLNE
$425M
| $276K | ﹤0.01% |
108,249
+6,994
| +7% | +$18.4K |
|
|
EPE
2545
DELISTED
EP Energy Corporation
EPE
| $276K | ﹤0.01% |
58,161
+12,841
| +28% | +$65.7K |
|
|
SIGM
2546
DELISTED
Sigma Designs Inc
SIGM
| $275K | ﹤0.01% |
43,996
+1,515
| +4% | +$9.33K |
|
|
CETV
2547
DELISTED
Central European Media Enterprises Ltd
CETV
| $274K | ﹤0.01% |
88,393
+3,244
| +4% | +$9.07K |
|
2548
Lifetime Brands
LCUT
$191M
| $273K | ﹤0.01% |
13,580
+5
| +0% | +$82 |
|
2549
Anterix
ATEX
$1.81B
| $271K | ﹤0.01% |
12,380
+461
| +4% | +$10.4K |
|
|
COOP
2550
DELISTED
Mr. Cooper
COOP
| $271K | ﹤0.01% |
15,583
+688
| +5% | +$11.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.